Amarin Corp Plc (AMRN)

[invest2992]

Thanx, but I am still somewhat confused. Total events of 1612 is 20% of population in 5 or 6 years after start of clinical testing. I assume that is 5.2% per year. You say 15% efficacy of vascepa over placebo. But what if it is much better. We can't go to either 1612 or 967 if vascepa is dramatically better than placebo. It would be unconscionable. Also, the better V is the longer it will take to get to the 60 percent milestone of 967.
If V is 0% better than P, 484V+484P=968 in about 2 years after full enrollment.
If V is 20%better than P, 440 + 528=968 in about 2.5 years.
If V is 50% better than P, 387+ 581=968 in about 2.8 years.
And if V should be 75% better than P, 352 + 616 in about 3 years.
The better V is, the longer it will take to get to the targeted markers!